SOD2 and metabolic dysfunction-associated steatohepatitis: Thus, C47T variant in the mitochondrial enzyme SOD2 is linked to advanced fibrosis in NASH [23], whereas mitochondrial UCP2-866 G > A polymorphism reduces risk of NASH progression [24].